While most of the symptomatic focus of COVID-19 has been on the respiratory effects of the virus, other manifestations of the disease are beginning to come to light as more data are collected and people who were previously infected with COVID-19 survive their infection and continue to be monitored. A new review in JAMA Neurology provides … [Read more...]
New Information on the Neurological Manifestations of COVID-19
New Data on How Tai Chi Helps Patients with Cardiovascular Disease
It has long been recognized that regular exercise promotes health, and it has also been established that it can improve well-being amongst adult patients suffering from cardiovascular disease. Tai Chi, a mind-body Chinese martial art that is popular for both defense training and exercise, has been shown to provide physical benefits to patients. … [Read more...]
COVID-19 and Ibuprofen: What is the Relationship?
There has been a lot of confusion in recent weeks about how ibuprofen may increase risks for contracting the novel coronavirus or impact the severity of the illness resulting from COVID-19 infection. Questions began after the publication of a paper in The Lancet Respiratory Medicine that pointed to the possibility that ibuprofen can increase … [Read more...]
New Data on Why Step Count Influences Blood Pressure
Several years ago, a study investigating the impact of daily steps on our overall health led to the widespread idea that we should aim to take at least 10,000 steps each day. However, there has since been skepticism amongst hospital based physicians and others in the medical community about the actual benefit of this exercise, with people pointing … [Read more...]
A COVID-19 Vaccine: Clinical Trial Begins
A 43-year old woman with two children has become the first study participant in a phase 1 clinical trial for an experimental vaccine against the spreading coronavirus. She was administered the vaccine, mRNA-1273, on March 16th. This move marks the official start to the open-label trial and what researchers hope will lead to the first approved … [Read more...]